SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote (9454)12/16/2002 2:20:05 PM
From: tom pope   of 9719
 
Morgan Stanley weighs in, from Briefing:

Corixa: odds of Bexxar approval may be slipping - Morgan Stanley (6.99 +0.24) -- Update --
Sources are telling us that Morgan Stanley now believes that the odds of CRXA's Bexxar getting approved by the FDA have slipped below 50%; if Bexxar is not approved, competitor IDPH will be the likely beneficiary.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News